 Boston, Massachusetts--Newsfile Corp. - May 25, 2021 - Berman Tabacco, a national law firm representing investors, is investigating potential violations of the federal securities laws by Adamis Pharmaceuticals Corporation NASDAQ: ADMP Adamis or the Company. Adamis purports to be a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The Company is based in San Diego, California.On January 29, 2021,... 